Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4
Abstract
Authors and Affiliations
Amirhossein Sahebkar
Keywords
Related Articles
- EP ID EP78092
- DOI -
- Views 103
- Downloads 0
First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder
Fibrosing cholestatic hepatitis (FCH) is a less common but well-recognized severe complication of recurrent hepatitis C virus (HCV) infection post-liver transplant. This condition is fatal without successful treatment an...
Liver transplantation: A new risk factor for intestinal intussusceptions
Background. The epidemiology and clinical characteristics of nonalcoholic fatty liver disease (NAFLD) in South America are not well known. Brazil is a largest country in this part of the world and the present study aimed...
Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
Background and rationale for the study. Ultrasound assessment of the severity of non-alcoholic fatty liver disease (NAFLD) shows substantial observer variability. The purpose of this retrospective study is to develop a m...
Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
Introduction. Many of the 300,000 HCV-infected Canadians live in under-served and remote areas without access to HCV healthcare specialists. Telemedicine (TM) and advances in HCV management can facilitate linkage of thes...
Evidence for liver injury in the setting of obstructive sleep apnea
Introduction. Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are both strongly associated with obesity. Whether OSA is an independent risk factor for liver injury is uncertain. Objective. To...